Treatment of tuberous sclerosis complex manifestations in children with mTOR inhibitors.

Yesil, Sule; Kurucu, Burçak; Hamamci, Melda Berber; Yilmaz, Sükriye; Sahin, Gürses

Yesil, Sule; Kurucu, Burçak; Hamamci, Melda Berber; Yilmaz, Sükriye; Sahin, Gürses.

Yesil S; Department of Pediatric Hematology and Oncology, Ankara Etlik Integrated Health Campus, Ankara, Turkey. suleyesil@yahoo.com.
Kurucu B; Department of Pediatric Hematology and Oncology, Ankara Etlik Integrated Health Campus, Ankara, Turkey.
Hamamci MB; Department of Pediatric Hematology and Oncology, Ankara Etlik Integrated Health Campus, Ankara, Turkey.
Yilmaz S; Department of Pediatric Radiology, Ankara Etlik Integrated Health Campus, Ankara, Turkey.
Sahin G; Dr. Sami Ulus Maternity and Children's Health and Diseases Training and Research Hospital, Department of Pediatric Hematology and Oncology, Ankara, Turkey.

Childs Nerv Syst ; 40(3): 831-837, 2024 Mar.

Article en En | MEDLINE | ID: mdl-37947859

Asunto(s)

Everolimus; Esclerosis Tuberosa; Niño; Humanos; Femenino; Masculino; Everolimus/uso terapéutico; Esclerosis Tuberosa/complicaciones; Esclerosis Tuberosa/tratamiento farmacológico; Esclerosis Tuberosa/genética; Inhibidores mTOR; Estudios Retrospectivos; Serina-Treonina Quinasas TOR/genética; Serina-Treonina Quinasas TOR/metabolismo; Serina-Treonina Quinasas TOR/uso terapéutico; Sirolimus/uso terapéutico

Palabras clave

Treatment; Tuberous sclerosis complex; mTOR inhibitors

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esclerosis Tuberosa / Everolimus Límite: Child / Female / Humans / Male Idioma: En Año: 2024 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google